ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 186 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $718,000 | -10.4% | 57,680 | -1.4% | 0.28% | -12.4% |
| Q3 2016 | $801,000 | +83.7% | 58,480 | -0.8% | 0.32% | +78.9% |
| Q2 2016 | $436,000 | +15.6% | 58,980 | 0.0% | 0.18% | +9.8% |
| Q1 2016 | $377,000 | +1.3% | 58,980 | -0.8% | 0.16% | -5.7% |
| Q4 2015 | $372,000 | +7.2% | 59,480 | 0.0% | 0.17% | 0.0% |
| Q3 2015 | $347,000 | -30.0% | 59,480 | -0.8% | 0.17% | -26.0% |
| Q2 2015 | $496,000 | +4.2% | 59,980 | +3.8% | 0.24% | +0.9% |
| Q1 2015 | $476,000 | +15.0% | 57,780 | -4.1% | 0.23% | +12.6% |
| Q4 2014 | $414,000 | +16.6% | 60,280 | -8.4% | 0.21% | +11.9% |
| Q3 2014 | $355,000 | -16.3% | 65,780 | -1.2% | 0.18% | -11.9% |
| Q2 2014 | $424,000 | -21.0% | 66,580 | 0.0% | 0.21% | -18.9% |
| Q1 2014 | $537,000 | +18.3% | 66,580 | 0.0% | 0.26% | +15.1% |
| Q4 2013 | $454,000 | -52.0% | 66,580 | +29.5% | 0.22% | -56.6% |
| Q3 2013 | $946,000 | +8.5% | 51,430 | +3.2% | 0.52% | -0.2% |
| Q2 2013 | $872,000 | – | 49,830 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |